Decitabine and venetoclax for IDH1/2‐mutated acute myeloid leukemia is a research paper published in American Journal of Hematology (2021). On theSindex it has a DataRank of 1.4. It has been cited 25 times, with 18 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0.951
From 17 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 18 citers.
NIH Clinical Center
Grant: R01CA235622
NCI NIH HHS
Grant: P30 CA016672
FWCI
2.76
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords